The prospects of cariprazine in the treatment of schizophrenia.

about

Current Concepts and Treatments of Schizophrenia

P2860

Q58693044-49B62ECA-F096-415F-A53D-3DFCA74849E9

P2860

The prospects of cariprazine in the treatment of schizophrenia.

Item

http://www.wikidata.org/entity/Q42703421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The prospects of cariprazine in the treatment of schizophrenia.

@en

The prospects of cariprazine in the treatment of schizophrenia.

@nl

type

Item

label

The prospects of cariprazine in the treatment of schizophrenia.

@en

The prospects of cariprazine in the treatment of schizophrenia.

@nl

prefLabel

The prospects of cariprazine in the treatment of schizophrenia.

@en

The prospects of cariprazine in the treatment of schizophrenia.

@nl

P1476

The prospects of cariprazine in the treatment of schizophrenia.

@en

P2093

Jonathan R Scarff

http://www.w3.org/2001/XMLSchema#string

P2860

New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine

Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.

The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.

Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine.

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.

The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.

Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.

Mechanism of action of cariprazine.

Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.

P304

237-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/2045125317727260

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29090086

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5638160

http://www.w3.org/2001/XMLSchema#string

The prospects of cariprazine in the treatment of schizophrenia.

about

P2860

P2860

The prospects of cariprazine in the treatment of schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932